PLRZ

Polyrizon

--(--)

Market Open: --

--(--)

Post-Market: --

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

Prev.Close

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

Low

52 Week High

52 Week Low

About PLRZ

Polyrizon Ltd.

A biotech company, focused on the development and commercialization of innovative intranasal products

Industry

Biological Technology

Established Date

Invalid Date

Listing Date

10/29/2024

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.polyrizon-biotech.com

Security Type

Common stock

Office address

5 Ha-Tidhar Street, Raanana, 4366507, Israel

Business

Introduction

Polyrizon Ltd., was incorporated in Israel in January 2005. The company is a development-stage biotechnology company specializing in the development of Innovative Medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based protective barrier within the nasal cavity that prevents viruses and allergens from contacting nasal epithelial tissue. The company's C & C hydrogel technology consists of a mixture of naturally occurring building blocks, is provided in the form of a nasal spray, and can be used as a "biological mask" with a thin protective barrier inside the nasal cavity. The company is further developing certain aspects of its proprietary C & C hydrogel technology, such as bioadhesion and extended retention time at nasal deposition sites for intranasal administration. The company calls its standalone platform technology focused on API nasal delivery T & T.